Cholesterol is known to modulate membrane's biophysical properties plus influence in the function and trafficking of membrane proteins. We have shown that point mutations in the nicotinic acetylcholine receptor (nAChR) can evoke increased macroscopic responses upon cholesterol depletion and at the same time, some can result in a Slow Channel Congenital Myasthenic Syndrome (SCCMS) characterized by muscle weakness and fatigue. Our main goal is to characterize a cholesterol reduction treatment in a model in which both the SCCMS and the cholesterol sensitivity phenotype coexist, αC418W mutation. Using various approaches, we uncovered a fraction of αC418W located in caveolin‐1 rich domains, suggesting a non‐functional state and possibly susceptible to cholesterol levels. Cholesterol depletion by Lipitor® resulted in the rearrangement of these receptors to a now functional pool. After treatment, the model presented calcium overload, high caspase activity, lower motor activity and significant differentiation in relation to the neuromuscular junction and its volume under confocal microscopy. Better molecular understanding of the statins' role on membrane proteins and cholesterol's participation is crucial for novel approaches to old physiological phenomena's that haven't been solved. Ultimately addressing the biggest problem, are statins safe?
Cholesterol is known to modulate membrane's biophysical properties and influence function and trafficking of membrane proteins. Cholesterol levels may regulate the movement of membrane proteins from functional to nonfunctional pools. To study this, the nicotinic acetylcholine receptor (nAChR) is used as a model due to its location on a functional pool and also, recent findings indicate that a nAChR mutation (αC418W) displayed an increase in macroscopic response upon cholesterol depletion. The αC418W is the first nAChR mutation identified as cause for a congenital myasthenic syndrome. Using various approaches, we uncovered a fraction of αC418W nAChRs located in caveolin‐positive domains, captive in a non‐functional state and susceptible to cholesterol levels. Cholesterol depletion resulted in the relocation of these receptors to a functional pool. Using a transgenic mouse model bearing the αC418W nAChR, we studied the effects of Lipitor®. After 18 days of statin treatment, the number of nAChRs and the total number of endplates in the diaphragm of the mutant were reduced. As a result, a generalized weakness of the αC418W mutant is present and in some animals an average of 60% loss of spontaneous activity. Understanding the molecular basis for the side‐effects of statins is critical to prevent the collateral contraindications and also to improve therapeutic intervention in hypercholesterolemic patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.